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Six Italian Simmental cows were randomly assigned to 1 of 3 feed additive treatment 
sequences with Bentonite mycotoxin binders (B) arranged in a balanced 3 × 3 Latin 
square design with three 19-d experimental periods (T1, T2, T3), to investigate 
modifications in their metabolically-active bacterial communities using the RNA-based 
amplicon sequencing method. 
The bacterial community of milk was most dominated by four phyla: Firmicutes, 
Poteobacteria, Bacteroidetes and Actinobacteria, corresponding to the results reported 
from previous studies associated active milk flora using DNA-based methods. 
The bacterial community of milk was most dominated by three phyla: Firmicutes, 
Actinobacteria, and Proteobacteria, corresponding to the results reported from previous 
studies associated active cheese flora using DNA-based methods.  
In conclusion, the anti-mycotoxin Bentonite dietary additives resulted in neutral effect in 
metabolically-active microbial communities in milk and cheese.  









1.1. The value of Milk and Cheese products as nutritious and healthy foods  
1.1.1. Overview of Milk products 
Milk is a composite physiological fluid secreted by female mammals' mammary 
glands to assist neonatal adaptation by delivering bioactive components and nutrients at 
the same time. [7][41] Human milk feeding promotes the development of a digestive 
system and a healthy microbiome. Milk components contribute to the baby's immune 
homeostasis and defense against pathogenic bacteria. [6] Animal milk, along with breast 
milk, is one of the most important sources of nutrition for infants and babies. [41] The 
term "milk" regularly refers to cow's milk. When other animals' milk is sold 
commercially, it is spelled out, for instance, sheep milk or goat milk. [7] Milk and its 
myriad of products are not only the main constituents of the daily diet for people 
belonging to vulnerable groups like children and the elderly, but they also play an 
important role in nourishment and development throughout adult human life. Milk is, 
without a doubt, nature's most complete food with a rich supply of energy, protein, fats, 
lactose, vitamins, minerals, and essential amino acids. [41][42] 
The comprehensive analysis demonstrated that the benefits of drinking milk 
outweigh the harms when it comes to health-related outcomes. Positive associations were 
found for cardiovascular disease, stroke, high blood pressure, colorectal cancer, metabolic 
syndrome, obesity, type 2 diabetes mellitus, osteoporosis, and Alzheimer's disease. 
(Figure 1.1) [99][118] High-quality dairy proteins play a vital contribution in weight loss 
and later weight maintenance, as well as the prevention of obesity-related metabolic 
disorders, by regulating satiety and avoiding excessive energy consumption. Proteins 
simultaneously improve body composition, i.e., reduce body fat mass and maintain lean 
body mass. [99]  Furthermore, recent cohort studies have reported that fermented dairy 
products, particularly cheese and yoghurt, have a neutral or inverse correlation with the 
incidence of type 2 diabetes may be due to their favorable effect on the gut microbiota. 
[86][98] Other research has found that whey protein and its constituent amino acids can 
stimulate insulin secretion as a mechanism to improve postprandial glycemic control and 
lower type 2 diabetes risk. [86]  
The overall evidence suggests that high consumption of dairy products, especially 
the low-fat, calcium-rich types, does not increase the risk of cardiovascular disease. 
 




Specifically, with a milk intake of 200-300 ml/day, there is a risk reduction of 
hypertension and stroke. [99] Some constituents of milk such as casein and whey protein, 
unsaturated fatty acids, polar lipids have shown beneficial relationships with intermediary 
cardiometabolic endpoints. [86] Most of the bioactive peptides of milk proteins are hidden 
or partially visible in the native protein, but they can be activated when food is digested or 
fermented with lactic acid bacteria to liberate bioactive peptides. [83] Once bioactive 
peptides are released, they inhibit the angiotensin-converting enzyme (ACE), lowering 
blood pressure. [75] In addition, calcium and probiotic bacteria can help to prevent 
excessive cholesterol absorption into the bloodstream, which lowers the risk of 
cardiovascular disease. [41][108] The role of cow's milk and its products in 
cardiometabolic health is an area of active and ongoing research. [86] 
Milk provides a variety of nutrients that are necessary for building children's bone 
strength and density and their maintenance in adulthood, with the goal of preventing bone 
loss and osteoporosis in old age. [42] Calcium, protein, phosphorus, magnesium, 
manganese, zinc, vitamin D, and vitamin K are all required for normal bone health, 
according to the European Commission. With the exception of vitamin D, all these 
nutrients are naturally present in milk and dairy products. [99] Since fluid milk does not 
naturally contain vitamin D, it can be fortified with vitamin D by law in some countries to 
aid your body in absorbing calcium. [22][51] Even though calcium and/or vitamin D 
supplements are beneficial for those who are unable to meet their calcium requirements 
through food or who limit their sun exposure, current evidence does not support routine 
calcium or vitamin D supplementation for healthy adults without a specific bone 
pathology because it is not helpful and potentially harmful. [91]  
Dairy has been linked to a variety of cancers, both positively and negatively, but 
most of them are based on limited evidence and further studies are needed. The positive 
effects on carcinogenesis may be connected to calcium, lactoferrin, and fermentation 
products, while the negative effects may be related to insulin-like growth factor I (IGF-1). 
According to current meta-analyses, the association between milk intake and a reduced 
risk of colorectal cancer is primarily attributed to calcium from dairy products, with a 900 
mg/day dairy-calcium intake resulting in a 24% risk reduction. On the other hand, high 
consumption of dairy products, low-fat milk, cheese, and calcium may raise 3–9% of the 
risk of prostate cancer; however, the evidence is inconsistent. For female consumers, dairy 
products offer significant health benefits by reducing the risk of common and severe 
 




colorectal cancer and potentially breast cancer as well. From the male consumer side, the 
protective effects of dairy products in colorectal cancer are believed to outweigh the 
potential increased risk of prostate cancer. [42][99][118] 
 
Figure 1.1. Overall association between dairy product consumption and health outcomes 
↓ positive effect; ↑negative effect; → no effect 
Additionally, a high-level intake of milk might slightly increase the risk of 
Parkinson’s disease, acne, and iron deficiency anemia. Caution should be exercised in the 
presence of a potential allergy or intolerance to lactose. [118] A majority of the 
ingredients in milk and dairy products are easily absorbed by humans. However, lactose is 
intolerant by some individuals who are encouraged to choose fermented milk products 
with little or no lactose, are easy to digest, and include probiotic bacteria, a health-
promoting agent. [42] Many factors can influence the milk yield and composition 
dynamics such as nutrition, genetics, environments, level of milk production, stage of 
lactation, disease (related to breast health), season, as well as age of the cow. [69]   
1.1.2. Overview of Cheese products 
Cheese has long been a staple of the human diet, especially in the Americas and 
European countries. It was originally produced as a method of preserving milk. [110] 
Basically, cheesemaking is the process in which liquid milk (an unstable, bulky but 
nutrient-dense raw material) is converted into cheese (a more stable, flavorful, and 
concentrated product), in order to extend its shelf life, improve food's palatability and 
 




increase consumer satisfaction. [68] Cheese is also popular for its nutritional value and 
health benefits. Cheese contains some of the same essential nutrients as milk because it is 
made primarily of ruminant milk. These nutrients include proteins, bioactive peptides, 
amino acids, fat, fatty acids, vitamins, and minerals. [73][110] 
One of the significant advantages of cheese is that it has less lactose than raw milk, 
making it more acceptable for lactose-intolerant people. The main step of cheese 
production is the coagulation of the casein micelles to form the structure of the cheese, 
which can be accomplished in one of three techniques: a) by adding enzymes (rennets), b) 
by adding acids or a starter culture, or c) by acidification mixed with heating. [47] Along 
this process, the solid components (curds), which contain casein, calcium, and fat, are 
separated from the liquid parts (whey), which contain whey proteins (WP), lactose, and 
some minerals. Whey is drained off before cheese is formed resulting in the removal of a 
significant amount of lactose. Since the curds used to make hard cheeses contain less 
moisture than those used to make soft cheeses, hard cheeses have less lactose than soft 
cheeses. Moreover, lactic acid bacteria are able to digest the residual lactose in cheese 
curds during ripening. The longer a cheese is aged, the less lactose is left in the final 
product. Parmigiano Reggiano PDO is an example of a lactose-free hard-matured cheese. 
Lactose-free cheese can also be produced by incubating the cheese milk with lactase prior 
to renneting. [32]  
Controversy remains about the presence of saturated fatty acids (SFAs), trans-FAs, 
and cholesterol in dairy products, which has long raised concerns about the increased risk 
of cardiometabolic disorders. [86][92] However, evidence from randomized controlled 
trials over the last 5 years has indicated that high-fat dairy products, cheese in particular 
do not seem to raise total and harmful LDL cholesterol levels to the extent expected. 
Cheese consumption has also shown an inverse association with incidence of diabetes, 
stroke, adiposity, and inflammation in most published trials, implying that dairy fat affects 
cardiovascular health in an optimistic way. [42] Cheese is an outstanding example of a 
hypothesis that mitigates the predicted negative effects of SFAs on metabolic health when 
these fats are ingested within complex dairy food matrices. [86]  Moreover, several studies 
have highlighted the bioactivity of specific milk fat components that may be beneficial to 
human health. For instance, butyric acid and conjugated linoleic acid, as well as different 
phospholipids and sphingolipids located on the milk fat globule membrane are molecules 
with promising anticancer action. [92] 
 




1.1.3. Global and EU markets for bovine milk and dairy products  
Current American Heart Association (AHA) and European Society of Cardiology 
(ESC) diet and lifestyle recommendations continue to emphasize the consumption of fat-
free and low-fat (1%) dairy products in a healthy eating pattern, while liquid milk and 
yogurt remain part of joint American Diabetes Association (ADA)/European Association 
for Study of Diabetes (EASD) nutrition guidelines, and as part of a “no-one-size-fits-all” 
answer to diet and T2D by the ADA's 2019 Consensus Report. [86][104] 
The milk delivered to dairies is processed into a wide range of fresh and processed 
products. During the decade of 2020, the world's per capita consumption of fresh dairy 
products is expected to rise by 1.0% per year. The highest demand comes from India, 
Pakistan and Africa, while demand in Europe and North America remains stable and 
shows a tendency downward. Meanwhile, consumption rates of processed dairy products 
(particularly cheese) vary across regions, depending on preferences and urbanization 
levels. The majority of total cheese consumption takes place in Europe and North 
America, where per capita consumption is projected to increase further. [30][76] To meet 
the large demand, global milk production in 2020 was recorded to increase by about 2% 
compared to 2019, reaching nearly 906 million tonnes. [35] The European Union is the 
second-largest milk producer and the largest milk exporter with almost 30% of global 
exports. [18] Furthermore, with stringent guidelines for bacteria and somatic cell counts in 
raw milk, the EU is committed to ensuring safe dairy products derived from healthy 
animals. [16] 
On a global scale, bovine milk still remains the most commonly produced and 
consumed milk thanks to some cows’ advantages over other dairy animals in regard to 
udder size, milk storage capacity, ease of milking, as well as milk yield. [30][34] The 
Holstein-Friesian breed accounts for 90% of the total cattle’s milk production and is the 
breed with the highest milk production. [10] Despite the fact that developed countries 
have fewer milking cows than developing countries, their livestock gives high milk yield 
owing to breeding selection and improved diets. [34] Table 1.1 reveals the milk yield of 
cows in Europe from 2017 to 2020, as well as the rate of milk self-sufficiency calculated 
using the formula: 
% Self-sufficiency Milk = C/(C+I-E)  
 




where C is Milk Deliveries, I is Import in Milk Equivalent, and E is Export in Milk 
Equivalent. [19] 
Table 1.1. Annual average cow milk yield in EU-28 (kg/year) and the milk self-sufficiency rate 
(2017-2020) 
Year 2017 2018 2019 2020 
Dairy Cows ('000 head) 23.312 22.906 22.627 20.565 
Milk deliveries (Tonnes) 156.086 157.415 157.874 160.404 
Cow milk yield (Kg) 6.696 6.872 6.977 7.800 
% Self-sufficiency rate 113,7% 112,9% 115,6% 114,8% 
Obviously, in recent years, the volume of milk production has been steadily 
increasing, reflecting the growing impact of this agri-food industry in the EU market. [16] 
EU dairy industry mainly focuses on exports due to the fact that the overall milk 
consumption has been declining and the self-sufficiency rate is greater than 100%. [18]  
1.2. Mycotoxins 
1.2.1. Mycotoxins contamination in forages and silages, the main component of 
dairy cow diets 
Mycotoxins are typically described as small molecules of secondary metabolites that 
are generated by moulds (e.g., filamentous micro-fungi), of which Aspergillus, Fusarium 
and Penicillium genera are considered to be the main manufacturers whose spores are 
widespread and, in some conditions, can develop on vegetal foods and feeds. (Figure 1.2) 
[9][84][85]  
 
Figure 1.2. Cultures of Aspergillus flavus and Aspergillus parasiticus, respectively,  
both producers of aflatoxins, on Sabouraud Agar 
 




Mycotoxin-contaminated foods and feeds have been shown to pose potential risks to 
the safety and quality of products in the food chains, human health, animal welfare, 
economic growth, domestic and international trade. [27][29] According to the Food and 
Agriculture Organization of the United Nations (FAO), at least 25% of the food crops 
over the world are facing mycotoxin problems, including cereals, nuts, oilseeds, fruits, 
beans, spices, and a variety of forages. [29][90] In addition, the result of a ten-year (2008–
2017) survey conducted by BIOMIN Research Center on the global incidence of 
mycotoxins reported that nearly 88% of animal feed and feed raw materials samples that 
were collected from 100 countries tested positive for at least one mycotoxin, and 64% of 
these samples were co-contaminated with more than two mycotoxins. The analysis also 
revealed regional differences in occurrence trends, with climate and weather playing a 
crucial role in governing these trends. [43] Approximately 400 fungal metabolites are now 
recognized as mycotoxins, of which aflatoxins (AFs), ochratoxin A (OTA), zearalenone 
(ZEN), fumonisins (FBs), trichothecenes such as deoxynivalenol (DON) and T-2 toxin (T-
2) are the most concerning in terms of food safety and government regulation. (Figure 1.3, 
Table 1.2) [84]   
 
 
Figure 1.3. Chemical structures of major mycotoxins found in food and animal feed 
 









Mycotoxigenic fungi Main effects in animals 







Ochratoxins OTA Penicillium verrucosum, 
Penicillium viridicatum, 
Aspergillus ochraceus 
Nephrotoxicity, mild liver 
damage, immune suppression. 
Zearalenone ZEN Fusarium graminearum, Estrogenic effects (edema of 
vulva, enlargement of uterus), 
atrophy of ovaries and testicles, 
abortion. 
Fumonisins FB1, FB2 Fusarium verticillioide, 
Fusarium proliferatum 
Pulmonary edema (pig), 
Leukoencephalomalacia (horse), 
nephrotoxicity, hepatotoxicity. 
Trichothecenes DON, 3- or 15-Ac-
DON,  
NIV (type B) 
T-2,  






Immune effects, haematological 
changes, dermatitis, oral lesions, 
gastrointestinal disorders 
(diarrhoea, reduced FI), 
gastrointestinal haemorrhage, 
edema. 
Mycotoxins enter the ration of farm animals through fungal infection of plants and 
subsequent utilization of mouldy crops as ingredients of feed. [107] A wide range of 
mycotoxin-producing moulds can naturally contaminate forages and cereals both before 
and after harvest, during transport and storage, or after ensiling during feed-out. [77] 
Mycotoxin mixtures are made up of pre-harvest toxins that are mostly produced by 
Fusarium species in crops, or post-harvest toxins that are frequently produced by 
Aspergillus and Penicillium species in silage or hay under storage conditions. [59] There 
are some physicochemical factors that influence the incidence of fungal infections and 
development, including the temperature, humidity, water activity (aw), the presence of 
oxygen, the nature of the substrate, and pH conditions. [23] Rodents, birds, and insects 
may contribute to infestation by producing physical lesions on plants, allowing fungal 
spores to penetrate. [115] Besides that, poor harvesting methods coupled with 
inappropriate drying, handling, packaging and transportation conditions also enhance the 
risk of mycotoxin formation. [107] 
 




The ensiling process of forages can eliminate some mycotoxigenic fungi due to low 
oxygen and low pH conditions. Normally, Fusarium spp. thrive in the field but cannot 
survive in preserved forages that have been compacted and sealed hermetically; in 
contrast, Penicillium spp. and Aspergillus spp. as well as a few Fusarium species (e.g., F. 
oxysporum, F. solani, or F. verticillioides) can endure the silage conditions and may 
produce additional mycotoxins. Furthermore, mycotoxins produced prior to ensiling may 
remain stable and unchanged during the silage process; for example, ZEN formed from 
the field can be detected in well-preserved silages devoid of F. culmorum activity. [103] 
In particular, the availability of oxygen in ensiled forages that has not been fully pressed 
and sealed, or the entry of oxygen through the cutting edge during feed-out, could allow 
the growth of Fusarium spores, or reactivate of inactive fungal spores in silage. [40]  
1.2.2. The negative impact of mycotoxins on human and dairy cow health 
Effects on cow health and performance 
The exposure of mycotoxins in animals is almost often unintentional, through 
ingestion, inhalation, skin contact, or other routes, resulting in the diseases collectively 
called mycotoxicoses. The majority of incidents in both animals and humans are caused 
by the consumption of contaminated food. [74] Ruminants are better protected from 
mycotoxin effects than monogastric thanks to symbiotic bacteria in their rumen can break 
down or deactivate poisonous compounds and hence reduce contamination contents. [77] 
However, ruminant diets are more diverse than monogastric such as swine and poultry, 
including cereals, protein feeds, grazed forage, sorghum silage, and other compositions; as 
a consequence, increases the risk of mycotoxin exposure. [40] The rumen fluid, which 
contains a varied microbiome, is regarded to be the first line of defense against 
mycotoxins such as ZEN, OTA, and T-2 toxin, but it is useless against AFB1, fumonisin, 
and patulin. This defense barrier can be damaged in certain scenarios, such as animal 
disease, dietary changes, and high levels of mycotoxin contamination. [5]  
On both humans and farm animals, mycotoxin has a diverse mode of action includes 
cytotoxicity, hepatotoxicity, nephrotoxicity, teratogenicity, mutagenicity, carcinogenicity, 
immunosuppression, and estrogenic effects. After ingesting one or more mycotoxins even 
at low concentrations, infected cows may experience anorexia (lack or loss of appetite for 
food), reproductive and metabolic disorders, reduced milk output or poor weight gain, get 
sick, or even death. (Table 1.3) [63][84] Such effects result in serious economic losses, 
especially significant domestic animal mortality, increased veterinary care expenses and 
 




decreased production efficiency. [23] Commonly, clinical signs and pathological lesions 
of mycotoxicoses in dairy cows can vary greatly depending on several factors such as the 
type, dose, duration of intoxication; species, breed, sex, age of cows; as well as synergistic 
effect along with other toxins and/or pharmacologically active substances. [23][84][105] 
In addition, because feed storage conditions can result in the presence of mycotoxigenic 
moulds, cows fed fresh pasture are assumed to be less susceptible to mycotoxins than 
cows fed dry or concentrated feed, primarily corn silage and hay. [5] 
Mycotoxicoses syndromes can lead to acute toxicity with a sudden onset and 
apparent signs of disease in liver, kidney, epithelial tissue, immune system, and central 
nervous system, or even mortality. [9][85] In livestock farm environments, mycotoxin 
effects are rarely acute but predominantly chronic, defined by low-dose exposure over a 
long period and concealed disorders with impaired digestion, productivity, and fertility. 
[9][40] The primary chronic toxicity is the induction of cancer, particularly of the liver 
(e.g. FB1 or AFB1). Some mycotoxins (AFB1 is one example) can interfere with DNA 
replication, which can result in mutagenic or teratogenic effects. [85] Some toxic residues 
will transfer into certain compartments of ruminants and will present in edible animal 
products, such as meat, offal, milk, and eggs, causing food safety problems and 
endangering human health. [59]   
Table 1.3. Summary of effects of common silage mycotoxins in ruminants 
Mycotoxin Effects in ruminants 
Aflatoxin  
B1, B2, G1, G2 
Decreased feed efficiency and weight gain. Decreased milk production. 
Decreased milk quality and safety. Compromised immune. Liver 
malfunctions.  
Ochratoxin A 
No significant toxicity to cows when fed alone in naturally occurring doses. 
Carry-over of the toxin into milk is minimal. 
Zearalenone 
Infertility, decreased milk production, and hyperestrogenism. Carry-over of 
the toxin into milk is negligible. 
Fumonisin  
B1, B2, B3 
Decreased performance probably due to feed refusal. Mild liver disease. 
Extent of transfer into milk of ruminants is negligible.  
Deoxynivalenol 
Gastrointestinal problems and decreased performance probably due to feed 
refusal. No evidence of carry-over into milk of cows. 
T-2 toxin 
Immunosuppression in cattle because of decreased antibody production, 
neutrophil function, and lymphocyte blastogenesis. Infertility and abortion in 
late gestation. Extent of transfer into milk of ruminants is negligible.  
 
 




Effects on human health, especially carcinogenic effect 
Human exposure to mycotoxins can occur directly through eating cereals or 
indirectly through digesting animal products, resulting in a wide range of negative 
consequences. (Table 1.4) [65] Due to the obvious toxicity and carcinogenicity of 
mycotoxins in food, at least 99 nations (representing around 87 percent of the world's 
population) proposed mycotoxin regulations for food or animal feed by the end of 2003. 
[39][102]  
Table 1.4. Mycotoxins and their effects on human health 
Mycotoxin Effects in ruminants 
Aflatoxin B1/M1 Liver cancer 
Ochratoxin A Possible carcinogen, kidney damage 
Zearalenone Natural oestrogen (effects undefined) 
Fumonisin B1 Possible carcinogen, kidney/liver damage 
Deoxynivalenol Nausea, diarrhoea, vomiting and headache 
T-2 toxin Nausea, diarrhoea, vomiting and headache 
Many studies have relied on the description of aflatoxin B1 metabolism to illustrate 
the metabolic fate and toxicokinetics of mycotoxins in human and animals. (Figure 1.4) 
[72] The completeness of absorption of aflatoxin B1 after oral exposure via food products 
have been shown using radiolabelled aflatoxin B1 in some experimental animals such as 
rats and monkeys. Since AFB1 is lipophilic xenobiotic, it can also be absorbed rapidly, by 
passive diffusion, from the small intestines (especially the duodenum) into the plasma, 
and then distribute to liver, which is regarded as the main site of aflatoxin transformation. 
[101] Metabolism of AFB1 divided into two phases: Phase I involves oxidative reactions 
by cytochrome P450 enzymes, to bioactivation of AFB1 and gives rise to several reactive 
metabolites/intermediates (epoxides), phase II generally serve as a detoxifying step that 
involves conjugation of the mycotoxins or their metabolites to another molecule, such as 
glucuronide or amino acids. Currently, the hazardous or carcinogenic effects of AFB1 are 
thought to be connected to both the rate of activation and the rate of detoxification at 
phase I and phase II of metabolism. [25] 
 





Figure 1.4. The metabolism and biotransformation pathways of AFB1 in lactating dairy cows 
Aflatoxins are very toxic compounds that the International Agency for Research on 
Cancer (IARC) has designated as Group 1 carcinogens in humans. Aflatoxin exposure in 
the diet is one of the major risk factors for hepatocellular carcinoma. Among AFs, AFB1 
is the most potent carcinogen.  Moreover, AFB1 can act as “pro-carcinogen” because it 
will be enzymatically bioactivated by hepatic CYP450 to form reactive AFB1-8,9-epoxide 
(AFBO), the ultimate carcinogenic form. This resulting reactive epoxide can intercalate 
the DNA and binds covalently, upon alkylation reaction, to the N
7
 position of guanine, 
causing DNA damage. The three AFBO-induced DNA lesions (AP, AFB1-N7-gua, and 
AFB1-FAPy) have been known as the main precursors of AFB1 genotoxic and 
carcinogenic effects. [8][56] AFs exposure is thought to be responsible for roughly 26% 
of the 550,000-600,000 new cases of liver cancer diagnosed each year around the world. 
[3] All nations that enacted regulations related to mycotoxins in foods and feeds in 2003 
have regulatory limitations for aflatoxin B1 alone or the sum of the aflatoxin B1, B2, G1 
and G2. [39] 
Fumonisin B1 (FB1) belongs to Group 2B possible carcinogen to humans, though it 
does not appear to interact with DNA. FB1 exposure has been shown in animal studies to 
cause neural tube abnormalities, raising worries that this mycotoxin could have 
comparable consequences in humans. OTA has the potential to be nephrotoxic, 
hepatotoxic, neurotoxic, carcinogenic, and immunotoxic. ZEN and its derivatives are not 
 




considered carcinogenic; however, they have estrogenic and anabolic activity, which 
causes precocious puberty in children. DON (vomitoxin) can inhibit protein synthesis, 
resulting in acute vomiting, diarrhoea, abdominal pain, headache, and fever. [5][85] 
1.2.3. Milk and cheese products contaminated with aflatoxin M1 pose a health 
risk to consumers 
Normally, mycotoxins found in dairy products can originate from one of two 
sources: (1) indirect contamination occurs when lactating animals consume feed 
containing mycotoxins, which are metabolized and pass into the milk, such as aflatoxin 
M1 (AFM1); or (2) direct contamination occurs when molds are intentionally or 
unintentionally grown on dairy products. [95] In raw milk, aflatoxin M1 (AFM1) is the 
most frequently detected mycotoxin and raised concern about the likelihood of exceeding 
the EU limit of 0.05 μg/ kg in milk, indicating a significant threat to dairy consumers. 
(Figure 1.5) [3][20]  
 
Figure 1.5. Major AFB1 and AFM1 contamination routes and health effects on humans 
AFM1 is a hydroxylated metabolite of AFB1, which is biotransformed by 
cytochrome P450 enzymes in the liver of dairy cows fed with AFB1 contaminated feed. 
(Figure 1.6) [3][48] AFM1 was identified in milk 12-24 hours after the first AFB1 
ingestion, and after a few days, it reached a high level. [36] Some investigations 
demonstrated that when cows eat AFB1-contaminated feeds, a portion of the AFB1 is 
digested in the rumen, forming aflatoxicol. The remaining fraction is passively diffused in 
the gastrointestinal tract and hydroxylated to AFM1 in the liver. [37] Due to the hydroxyl 
group, these compounds are highly hydrophilic, allowing their elimination through urine, 
 




bile, feces, and milk. [5] (Figure 1.6). Risk assessments revealed that AFM1 can leads to 
carcinogenicity, mutagenicity, genotoxicity, teratogenicity, and immunosuppression. [72] 
AFM1 is heat resistant and chemically stable within the range of conventional food 
processing conditions (80–121°C); therefore, it still persists throughout boiling and frying, 
or even not completely inactivated by pasteurization, sterilization, or other milk treatment 
processes. [5][82]  
 
Figure 1.6. Hepatic biotransformation of aflatoxin B1 into aflatoxin M1 
Furthermore, milk is not only consumed as liquid milk but is also used as an 
ingredient in the production of related products, such as cheese. AFM1 is relatively stable 
in raw and processed milk, so cheese prepared from such milk will be contaminated as 
well. AFM1 contents in cheeses can remain constant even during processing and ripening. 
[95] Mycotoxins in cheese vary depending on cheese type or processing parameters such 
as temperature, pH, pressing time, and so on. [65] Some other mycotoxins detected in 
cheese are the consequence of the accidental proliferation of wild strains such as 
Penicillium species. Sometimes, moulds are purposefully introduced into some cheeses, 
such as Camembert and Roquefort. The risk of mycotoxins in cheese increases 
dramatically if toxigenic molds are allowed to develop during manufacture and storage. 
[65][95] 
Given the adverse effects mycotoxin may cause in milk and cheese consumers 
(especially children and old age), many countries, particularly European countries, have 
established regulations relating to mycotoxins, including the maximum residue levels 
(MRLs) of AFM1 in milk and dairy products, in order to protect the public health. 
(Firgure 1.7) [67][102] According to the European Commission, the MRL for AFM1 is 
 




0.05 μg/L in milk and 0.025 μg/L in milk-based infant meals. MRL levels in other nations 
such as Syria, the United States, China, and Brazil, are higher (for example, in the US, the 
limit is 0.5 g/L). From a global viewpoint on the prevention of toxicity, the management 
of mycotoxins levels, in particular AFM1, in milk is a mandatory requirement for health 
and regulatory objectives. [52] Infants' exposure to AFM1 is more concerning since their 
ability to metabolize carcinogens is generally lower than that of adults, making them more 
susceptible. [48]  
 
Figure 1.7. Worldwide limitation of aflatoxin M1 in milk 
1.3. The addition of mycotoxin binder to cattle feeds to reduce mycotoxin 
exposure 
Although the agricultural and feed industries' primary goal is to prevent mycotoxin 
infection in the field and during storage by employing good agricultural and storage 
practices (GMP), the complete absence of mycotoxins in dairy cow feed can be difficult 
to achieve, necessitating the use of detoxification methods. [107] A variety of methods 
have been applied to decrease the presence of mycotoxins in feed; however, dietary 
addition of adsorbent clays is the most prominent approach and is extensively utilized by 
farmers and fodder manufacturers. Clay minerals are finely granulated earthy substances 
(diameter less than 2 mm) that exhibit plasticity when moistened or non-plastic and hard 
when dried. [23] These substances are usually added to animal feed as a non-nutritive 
additive to prevent feedstuff from lumping, which is a risk of microbial contamination. 
[27] Moreover, mineral adsorbents are abundant in nature, are affordable, can be 
chemically manipulated to enhance mycotoxin-adsorption capacity. Several studies have 
examined the potential of mineral adsorbents to bind mycotoxins in vitro, and their partly 
or fully protective efficacy against mycotoxicosis in vivo. [27] The use of high-dose 
mycotoxin binder can also diminish the concentration of AFM1 that carry-over into the 
 




milk and further increase the clearance rate. [88] Since 2009, the European Commission 
has officially authorized the use of such anti-mycotoxin agents through the amendment 
and issuance of regulations related to the new technological feed additives. (EC No 
386/2009). [27]  
Mycotoxin binders are added to the cattle feed to prevent mycotoxins from being 
absorbed in the gastrointestinal tract, as well as their transport to the blood circulation and 
target organs, decreasing their bioavailability after ingestion, and thereby limiting the 
deleterious effects of mycotoxicosis in individuals. [61] The main mechanism of these 
binders is forming mycotoxin-adsorbent complexes by different types of interactions such 
as hydrophobic binding, hydrogen bonds, or ion-dipole interactions. These complexes is 
able to pass through the animal and is then excreted via the faeces. [107] Table 1.5 
presents a summary of the major clay adsorbents currently used for sequestering 
mycotoxins [27]. According to EFSA in 2009, mycotoxin-binding agents can be 
categorized into silica-based inorganic compounds or carbon-based organic polymers 
(Figure 1.8).  [15]  
Table 1.5. Summary of physicochemical properties of mineral adsorbents commonly used for 
binding mycotoxins 





Mode of formation 
Bentonite 2:1 Lattice 53–83  370–490 Decomposition of volcanic ash in marine 
environment or silica bearing rocks such 
as granite and basalt. 
Kaolinite 1:1 Lattice 3–15  5–20 Rock weathering or the hydrothermal 
alteration process at high temperature or 
the alteration of primary minerals at low 
temperature (such as feldspar). 
Montmorillonite 2:1 Lattice  80–100 70–800 Weathering products in soils at 
moderately high temperature (200°C) 
Palygorskite   2:1 Lattice 4–40 300–600 Alteration of precursor minerals or 
precipitation from rock solution. 
Activated carbon  Pore – 300–4000 Pyrolysis of organic materials such as 
lignin, coconut shell, peat, hard and soft 
wood, lignite coal and carbonaceous 
materials. 
Zeolite 1:2 Lattice 180–600 500–700 Rock interaction with aqueous solution 
 








Figure 1.8. Classification of mycotoxin binders (adapted from EFSA, 2009). 
Bentonite is a type of phyllosilicate clay with a layered crystalline architecture that 
permits other molecules to be absorbed and a strong tendency to inflate when wet. [23] A 
basic structure of Bentonite (primarily made up of montmorillonite) is composed of 
several tens of stacked nanolayers (tactoids). Each platelet is made up of three layers, an 
octahedral layer comprising of Mg, Fe, Al and OH-groups, sandwiched between two 
tetrahedral layers with Si-O tetrahedrons. (Figure 1.9) [26][27][46] The performance of 
bentonite adsorption is highly influenced by its montmorillonite content and 
interchangeable ions. [107] Around 80 percent of the exchangeable cations are found in 
the interlayer spaces, which help to balance out the negative charges in the reticulated 
region. The enormous surface area and strong cation exchange capacity of the smectite 
group, along with this structure, make these compounds suitable adsorbents for low polar 
mycotoxins, enabling both cations and polar molecules to pass through. [23] The 
adsorption ability is often influenced by adsorbent parameters such as total charge, charge 
distribution, pore size, and accessible surface area, in addition to the physicochemical 
properties of target mycotoxins. [87] In numerous in vitro and in vivo trials, Bentonite 
clays have shown high efficacy in forming and firmly binding mycotoxin-adsorbent 
complexes to limit toxin bioavailability. [107] These clays have the capacity to bind 
minor mycotoxins like aflatoxin and ochratoxin A, but not bigger compounds like those 
found in Fusarium toxins. [87] AFs can adsorb at multiple sites, particularly the interlayer 


















Figure 1.9. Graphical abstract (A) and basic structure (B) of Bentonite clays 
Concerning the safety and efficacy of bentonite detoxifying agents, The European 
Food Safety Authority (EFSA) assessed and suggested that after being employed as a 
technological feed supplement, bentonite was observed to be non-genotoxic and non-
absorbable, offering no direct toxicological risk to the animal (EFSA, 2011). [107] On the 
other hand, there is still considerable debate about whether commercial mycotoxin 
binders, such as Bentonites, can have negative repercussions for the health and production 
of farm animals. In addition, there is a scarcity of research data regarding the impact of 
mycotoxins on animal products, such as cow milk. As a result, farmers and the feed 
industry must be cautious when supplementing these anti-mycotoxin mineral adsorbents, 
and further studies are needed in this area. [27]   
1.4. Microbial community of bovine milk and cheese  
1.4.1. Milk microbiota investigation in the omics era 
As stated above, milk is a nutrient-rich material with a neutral pH and high water 
activity, providing a perfect environment for the growth of a wide range of 
microorganisms. In the past, it was considered that a healthy udder and the milk it 








been introduced from numerous external contamination sources. [89] On the other hand, 
with the great developments in science and technology and the introduction of next-
generation sequencing (NGS) techniques, the existence of a diverse and complex 
microbial population in cow's milk was revealed, even in healthy mammary glands. [80] 
The methods used to investigate milk-associated microbiota evolved from traditional 
cultivation-based analysis to the most recent culture-independent, DNA-based techniques, 
which typically rely, at least in part, on the use of polymerase chain reaction (PCR) 
technology. One of the main benefits of this alternative is the ability to correct inaccurate 
outcomes from traditional research since it can identify even non-culturable species due to 
unknown nutritional needs. [89] DNA sequencing allows us to exactly specify the order of 
the nucleotides that make up the nucleic acid's primary structure, from that we can acquire 
the sequences of previously unknown species or to accurately identify particular samples 
by comparing them to databases. [62] The large-scale sequencing (NGS) can create more 
rapid, high-throughput tests by generating millions of sequenced reads in only a single 
run, allowing for far more detailed and precise estimation of microbial diversity. One 
limitation of NGS is that it requires advanced platforms and IT tools for the re-processing 
of the enormous quantity of data that is generated. [89] Futhermore, the availability of 
sequence databases and bioinformatics tools offers a great chance for taxonomic 
assignment of the microorganisms present at a high level of precision. [89]  
The majority of published milk microbiome data has resulted from DNA-based 
methods with amplification and sequencing of 16S rRNA genes. [1][21][89] The 
prokaryotic 16S rDNA, which codes for the small subunit (SSU) of ribosomal RNA, is 
made up of nine hypervariable regions (V1-V9) flanked by regions of highly conservative 
sequence. Because it is highly conserved across members of the domains Bacteria and 
Archaea, allowing the design of "universal" PCR primers, and its hypervariable regions 
show significant sequence diversity among different species, providing species-specific 
signature sequences, this gene is commonly used in microbial community fingerprinting 
and taxonomic classification. [49] Figure 1.11 shows the variable regions of 16S rDNA 
and the PCR universal primers. [1][55] To simplify the large datasets, the amplified pool 
of 16S rDNA fragments was grouped/clustered based on similarity to form operational 
taxonomic units (OTUs). Representative OTU sequences were compared to reference 
databases and used to compare biodiversity within and between samples. [111] 
 




Several fingerprinting approach have been widely used such as denaturing gradient 
gel electrophoresis (DGGE), terminal-restriction fragment length polymorphism (T-
RFLP), or microarrays. [49] In recent years, next-generation sequencing (NGS) 
technologies have empowered deeper sequencing and data analysis of various types of 
environmental samples than was previously possible using standard molecular biological 
techniques. [97] The commercially available Illumina MiSeq platform poses the great 
potential for 16S rDNA sequence studies, as it allows for relatively long reads of up to 
600 bp. Additionally, the newly designed universal PCR primers Pro341F and Pro805R 
targeting the V3-V4 region of bacterial rDNA were modified based on previously 
published universal PCR primer sets, to improve the coverage of existing sequences in the 
database and so obtain better result of prokaryote detection. [49] 
 
Figure 1.10. Hypervariable regions of 16S and PCR primers to amplify them 
 
In recent years, a wide range of meta-omics analyses have been widely applied and 
have substantially expanded our understanding of the milk microbial communities, 
including metagenomics, metatranscriptomics, metaproteomics, and metabolomics, which 
target DNA, RNA, proteins, and metabolites produced by the entire microbial community, 








Table 1.6. Features of the -omics investigations available for studying microbial communities 
Approach  Target molecule(s) Information 
provided 
Drawbacks 




Only bacteria are 
characterized 
Metagenomics Community DNA Taxonomic 
distribution and 
gene potential 
Issues with sequence 
annotation and costs 





Issues with RNA stability 
and data analysis 
Metaproteomics Community proteins Taxonomic 
distribution and 
protein expression 
Issues with protein 





Metabolic fluxes No direct link between 
metabolite and microbial 
taxonomy 
Although DNA-based methods can provides important information about 
community taxonomy and its functional potential, there is a lack of information related to 
microbiota activities under specific conditions or during specific periods. Due to the 
inability to differentiate among the genes originating from active, inactive, lysed, or dead 
cells, this method cannot determine the viability of the detected microbial communities, as 
well as their biological and metabolic activities. Therefore, when it comes to the scenario 
of the functional activity of milk microbial communities, this approach is deemed not 
feasible. The alternative RNA-based approach offers more promise thanks to the existence 
of a positive association between the content of ribosomal RNA (rRNA) and the metabolic 
activity of microorganisms, allowing the prediction of metabolically-active microbiome 
structures. [1][4] Following extraction, total RNA is reverse-transcribed to cDNA, and 
cDNAs are analyzed using high-throughput sequencing technologies (RNA-seq). 
However, many challenges remain in the research using this method, particularly sample 
preparation and handling caution due to RNA’s low stability and the ubiquitous presence 
of RNases, as well as bioinformatics issues relating to sequence reconstruction, 
annotation, and statistical analysis. [60]  
 




Some recent reports have noticed the discrepancies in the community profile 
between DNA and RNA-based studies. This finding demonstrated that DNA profiling 
data alone can lead to an underestimating of active members in the community, 
emphasizing the significance of using a complementary method to gain a broad general 
overview of not only of total and active members but also in the expected functionality. 
[4][93] Nevertheless, only a few studies have conducted RNA-based profiling of the 
microbial community found on milk and cheese to date. This could be due to the 
methodological and technical challenges the researcher encounters, such as developing a 
uniform process that evenly harvests all RNA transcripts from all species while 
simultaneously preventing degradation. 
1.4.2. Functions of microbial community in milk and cheese 
The active microbial community of breast milk is thought to contribute significantly 
to the development of the neonates’ GI tracts as well as the health of nursing mothers' 




 CFU/ml in 
healthy human breast milk. [53] With respect to the cows’ milk microbiota, most research 
has focused on how the microbial flora of milk changes as it is transformed into a food 
product, either for immediate intake or for transformation into specific dairy products 
(cheese for example). [89] Moreover, the analysis may be also interested in knowing how 
microbial species differ between cheese kinds and different cheesemaking procedures. 
[100] Some bacteria harbored within milk is able to transform the milk components such 
as lactose, to produce metabolic secondary products that could further be used as a 
substrate for the growth and the metabolism of other microorganisms. The diverse milk-
associated microbiota also plays an active role in determining cheese composition as well 
as specific cheese features, for instance, flavors and aromas. At the same time, bacteria 
capable of consuming milk sugars also became more abundant in composition. [89][100] 
In addition to its endogenous microbiota, once milked, raw milk is easily colonized by a 
range of other bacteria from the breast skin, milking machines, storage tanks, or the 
surrounding environment. Also, milk and cheese can be contaminated with potentially 
pathogenic bacteria (or their toxins) and hence can have serious effects on human health. 
[1] Moreover, sometimes microorganisms are introduced into dairy products on purpose, 
such as in mould-ripened cheese, or the strictly controlled starter cultures. [11][12] 
Indeed, by understanding the dynamics of the dairy microbiota, people can better control 
the qualitative, textural, sensorial, and biosafety characteristics of dairy products. [100] 
 




Therefore, it is necessary to cultivate more knowledge about the change of microbial 
composition in raw milk throughout milking, transportation, storage and processing. [1]  
Over the years, the importance of the microbiome in milk and milk products has 
been increasingly appreciated, so this microbiome has become the subject of many 
different articles. Despite the fact that the use of various investigation methods and the 
influence of various factors (both endogenous and exogenous) make a direct comparison 
and the integration of the obtained results more complicated, the typical composition cow 
milk microbiota registered a heterogeneous composition characterized by the high 






















 CFU/mL). In addition, bacteria with a fluctuating load, 
such as psychotropic Pseudomonas, Acinetobacter, and Aeromonas, have been found in 
the microbiota of cow milk. Furthermore, recent research using more sensitive methods 
than traditional ones revealed the presence of anaerobic bacteria such as Bacteroides, 
Faecalibacterium, Prevotella, and Catenibacterium.[89][100] 
To date, despite the recognition of the importance of microbial activity in dairy 
products, there is still relatively little research in this area. Most concerns are linked to the 
microbial ecology of raw milk, rather than their behavior in the context of animal health 
and physiology, or when cow diets change. [78][79] Associated with diet change, Zhang 
et al. used pyrosequencing of the 16S rDNA to evaluate the impact of two dairy cattle 
diets (high concentration versus low concentrate diet) on milk microbial populations. 
Generally, Actinobacteria, Firmicutes, Proteobacteria, and Bacteroidetes dominated the 
milk microbiota regardless of diet. The authors also suggested that differences in feeding 
strategy can associate differences in milk microbial communities. [117] Table 
1.7 summarizes some current findings on the composition of the microbial community in 
healthy cow milk.  
As far as cheeses are concerned, regardless of whether they are fermented in a 
natural manner or with the help of starter cultures, most cheeses contain a diverse 
combination of microbial populations that develop and alter during cheese manufacturing 
and ripening. Generally, the microbiome in cheese is diverse and varies from one type to 
another, although the predominant microorganisms for each type of cheese are often 
similar. Prokaryotic Archaea and Bacteria, eukaryotic yeasts and fungi, as well as viruses 
(mainly bacteriophages) are all make up the cheese microbiota. Cheese bacteria are 
 




mainly dominated by the Firmicutes (LAB, enterococci, staphylococci), Actinobacteria 
(corynebacteria, propionibacteria, bifidobacteria), and Proteobacteria (enterobacteria) 
phyla as showed in the research of Mayo et al. with the use of DNA-based profiling. [71] 
Table 1.7. Composition of the healthy cow milk microbiota 
Study Most revelant genera  
Kuehn et al. [64] Ralstonia, Pseudomonas, Sphingomonas, Stenotrophomonas, Psychrobacter, 
Bradyrhizobium, Corynebacterium, Pelomonas, Staphylococcus 
Oikonomou et al. 
[79] 
Faecalibacterium, unclassified Lachnospiraceae, Propionibacterium, 
Aeribacillus, Bacteroides, unclassified Clostridiales, Staphylococcus, 
Streptococcus, Anaerococcus, unclassified Xanthomonadaceae, unclassified 
Bacteroidales, unclassified Bacteria, Lactobacillus, Porphyromonas, 
Comamonas, Fusobacterium, Enterococcus, unclassified Carnobacteriaceae, 
Asticcacaulis 
Zhang et al. [117] Chryseobacterium, Streptococcus, Enterococcus, Stenotrophomonas, 
Brevundimonas, Lactococcus, Sphingomonas, Prevotella, Sphingobacterium, 
Helcococcus, Leucobacter, Butyrivibrio, Atopostipes, Bosea, Alcaligenes, 
Ruminococcus, Facklamia, Actinomyces, Sphingobium, Trueperella, 
Pseudomonas, Enterobacter, Comamonas, Megasphaera, Salinicoccus, 
Ochrobactrum, Lactobacillus, Mogibacterium, Peptococcus, Succiniclasticum, 
Myroides 
Diet modifications are expected to have an impact on the active microbiota of milk 
and cheese. Moreover, there are few comparative studies on the effects of the mycotoxin 
binder Bentonite on the community profile of the milk and cheese microbiota, and this 
area needs to be explored to determine better management strategies regarding the use of 
this substance as a dairy feed additive. In this study, we hypothesized that Bentonites feed 
additives may not cause negative effects on the phylogenetic diversity of dairy flora. If 
this hypothesis is confirmed, it will provide a theoretical basis for the safety monitoring of 
using this mycotoxin binder in bovine feed. 
 




2. AIM OF THIS WORK 
The role of mycotoxin binders in recent years has been highly appreciated as an 
effective method to prevent the negative effects of mycotoxin in human and animal 
healths, especially to prevent AFM1 toxicity in cow's milk fed with fungal feed. The 
addition of Bentonites toxin binders to dairy feeds is widely used worldwide; however, 
there is still a lack of studies evaluating the impact of this substance. The metabolically 
active microbiota in the milk and cheese matrix plays an important role in determining the 
quality of the product, including composition and flavor of dairy products; at the same 
time, they may contribute to the human gut microbiota diversity. The question is whether 
after dairy cows consume food supplemented with Bentonites, will this substance enter the 
milk and affect the microflora of milk? 
The aim of this thesis is to investigate the effect of Bentonite in cow's dietary 
supplement on the structure of metabolically active milk and cheese microbiota, by using 
a high throughput, RNA-based approach. Specifically, this method includes total RNA 
extraction, cDNA synthesis, and subsequent two-step PCR amplification of RNA-derived 
transcripts–amplicons using primers targeting bacterial 16S ribosomal RNA genes, 
followed by Illumina MiSeq platform sequencing. The 16S rRNA gene is profiled using 
the V3-V4 region as a marker for the phylogenetic diversity of the expressed bacterial 
community. This approach aims to allow a comparison among the relative amounts of 
active microbial taxa within different amounts of Bentonites added to the bovine diet. To 
the best of our knowledge, there are currently no studies reporting changes in the structure 
of the active microbial communities in cow's milk and cheese associated with the 
mycotoxin binder Bentonites. 
 




3. MATERIALS AND METHODS 
3.1. Animals, treatments and experimental design to investigate the effect of 
Bentonite clay  
The study was conducted to investigate the effect of Bentonite clay added to the 
cows’ diet on the active microbial communities of milk and cheese from November 2020 
to June 2021. A total of six lactating multiparous (parity 2 to 3) Italian Friesian cows in 
plateau lactation phases (219 ± 37 DIM) were randomly assigned to 1 of 3 feed additive 
treatment sequences (B) arranged in a balanced 3 × 3 Latin square design with three 19-d 
experimental periods (T1, T2, T3). A Latin square design means the arrangement of t 
group of trials, each of which is repeated t times, in the design so that each group of trials 
appears accurately once in each row and column. This experimental design is useful 
because it can aid the case we have several factors and we want to keep them separate, it 
allows experiments with a small number of runs and decrease systematic error due to rows 
and columns. [24][112] The first 24-d acclimation was used to ensure animal adaption to a 
new diet. A 9-d washout interval between periods was imposed to minimize carryover of 
treatment effects between periods. Figure 3.1 depicts a schematic diagram of the 
experimental phases.   
 
Figure 3.1. Schematic design of each experimental period and its sampling time points 
All cows used in this study were housed in identical rearing conditions at the 
Experimental Farm of University of Padova, Italy. Cows were provided the same TMR 
basal diet to meet their nutritional requirements [4] and were fed ad libitum. From d 1 to 
19 of each additive treatment period, Bentonite clay was top-dressed on the respective 
basal diet. Each cow was assigned an ID number, 88, 313, 437, 578, 632, and 988, 
respectively. The feed additive treatments were formulated to either: (1) the control B0 
group (basal diet without Bentonite additive); or (2) the B50 group (with 50g/day 
Bentonite additive); or (3) the B100 group (with 100g/day Bentonite additive). The exact 
protocols of feed additive treatments can be found in Table 3.1.     
 




Table 3.1. The Bentonite additive treatments during three 19-day periods (T1, T2, T3) 
Period 
Treatment 
T1 T2 T3 
B0 88 578 313 437 988 632 
B50 632 437 88 988 313 578 
B100 313 988 632 578 88 437 
3.2. Sampling procedures 
3.2.1. Milk sampling and pretreatment 
Each period of the Latin square lasted 19 d, with milk samples collected on d 17 in 
the morning between 6:00 and 7:00 (before morning feeding) for analysis of the active 
milk microbial community. An aliquot of 50 ml was obtained from each cow under sterile 
conditions by washing and drying cow’s teat with pre-dipping (Figure 3.2) and alcohol 
solution to prevent teat apex bacterial contamination of the milk, followed by manual 
removal of the initial 3 streams of milk. Milk sample collections were transported and 
preserved in frozen conditions for further analysis. 
 
Figure 3.2. A rapid-acting foam pre-dipping 
In the lab, milk samples were centrifuged at 2683g for 20 min (at 4°C), and then 
discarded the cream (fat) and the supernatant. The pellets were re-suspended with 1 ml of 
PBS (phosphate-buffered saline) which is an isotonic and non-toxic buffer solution. Re-
suspended mixture was centrifuged at 12000g for 1 min (at 4°C), removed supernatant 
and washed with 500 μl of PBS. The obtained re-suspensions were separated into two 
sterile tubes (250 μl each) and following by the centrifugation at 12000g for 1 min (at 
4°C). Supernatant was eliminated and pellet was mixed with 1 ml of TRIZOL Reagent 
that is useful for isolating total RNA by preserving the integrity of RNA during tissue 
 




homogenization and cell disruption. Cells were disrupted with Zirconia Silica beads 
(0.25mm) on a TissueLyser (Qiagen, Hilden, Germany) in frequency of 30 Hz (1/s) x 1 
min. Final pre-treated milk samples were stored at -80 °C to be used in further RNA 
extraction.   
3.1.1. Caciotta cheese making, sampling and pretreatment 
Table 3.2 summarizes some information related to the cheese-making process using 
raw milk that was carried out in this study.  
Table 3.2. Summary of Caciotta cheese making 




















CALDAIA 5 88+578 B0 36 6.6 3.2 681.763 24.810 11.4% 
CALDAIA 6 313+437 B50 37 6.12 5.3 752.543 51.099 12.2% 
CALDAIA 7 988+632 B100 36.9 6.5 3.8 780.960 14.517 12.7% 
CALDAIA 8 437+632 B0 36 6.74 3.5 704.293 38.740 13.7% 
CALDAIA 9 88+988 B50 34 6.8 2.8 612.680 12.171 10.8% 
CALDAIA 10 313+578 B100 36 6.69 3.3 542.957 17.673 10.6% 
CALDAIA 11 313+988 B0 36 6.67 3.6 634.513 25.282 10.6% 
CALDAIA 12 578+632 B50 30 6.62 3.5 621.488 14.983 12.4% 
CALDAIA 13 88+437 B100 24 6.68 3.0 856.410 21.420 10.7% 
 
Individual cow’s milk collected from the milking of the evening d 16 and the 
morning d 17 was stored at 4°C until the cheesemaking of the 17th day. Milk from cows 
in the same treatment group was pooled in equal amounts to reach the volume required for 
cheesemaking (34±4 L). Milk acidity traits averaged 6.6 (pH at 22°C) and 3.6 Soxhlet-
Henkel degrees (
0
SH)/50 mL (TA). Milk was heated to 39°C and a starter culture (TB1/A-
D, Bioagro srl, Thiene, Italy) was inoculated at concentration 0.03 g/L. To be noted, this 
starter culture contains a mixture of strains of streptococci and thermophilic lactobacilli; 
thus, they were predicted to be presented in the results.  
It needs to wait 40 min as an adaptation period. Then, calf rennet (MRI 8/2, Bellin 
Pietro, Vicenza, Italy) was added and sit quiet for 45 min. After the end of coagulation, 
curd was cut into walnut size and cooked at 42°C for 15 min. The curd was extracted and 
 




collected in Caciotta cheese molds until the pH reached to around 5.2. After the addition 
of salt, cheese was stored at 13.5°C, 80% relative humidity for 21 days.  
In the sampling process, cheese samples were obtained from the core of the cheese 
in three points as described by Figure 3.3. The samples were then crumbled and mixed 
well. 150mg cheese was weighed and transferred to each sterile tube, and mixed with 1 ml 
of TRIZOL Reagent. Cells were disrupted with Zirconia Silica beads (0.25mm) on a 
TissueLyser (Qiagen, Hilden, Germany) in frequency of 30 Hz (1/s) x 1 min. Final pre-
treated cheese samples were stored at -80 °C to be used in further RNA extraction for 
analysis of the active cheese microbial community.  
 
Figure 3.3. Cheese sampling regions 
3.3. RNA extraction and cDNA synthesis  
Each pre-treated milk sample was added 200 μL chloroform and vortexed for 15 
sec, left on ice for 10 min and centrifuged at 12000g for 15 min (at 4°C). The extracted 
RNA was purified using the RNeasy Minikit (Qiagen, Hilden, Germany) with an on-
column DNase digest step, following the instruction of manufacturer. Following 
centrifugation, the solution was separated into three phases, RNA remains only in the 
upper aqueous phase. The 450 μL of the upper aqueous phase was transferred to a fresh 
tube and mixed with 350 μL of 100% ethanol. This mixture (800 μL) was added to the 
column provided in the RNeasy Minikit (Qiagen) and centrifugated at 14000rpm for 30 
sec.  
For RNA extraction of cheese samples, the first step were required is 
homogenization with Zirconia Silica beads (0.25mm) on a TissueLyser (Qiagen, Hilden, 
Germany) (30 frequency 1/s, 1 min each), to facilitate stable emulsion consists of a 
uniform mixture. This step is only required for cheeses; for milk, we proceed directly to 
the RNA extraction. The further steps were the same as those described in the previous 
section on milk samples.  
 




One of the most important factors for good RNA extraction and handling is 
maintaining an RNase-free working environment such as work in a separate and aseptic 
area, use dedicated RNase-free equipment and reagents, wear gloves whenever handling 
RNA and reagents, as well as keep all tubes tightly closed when not in use. Also, RNA 
should be extracted as quickly as possible after obtaining samples, and always keep the 
sample tube on ice during experiments.  
The extracted RNA was evaluated using a Nanodrop ND-1000 (NanoDrop 
Technologies, Wilmington, DE, USA). The Nanodrop is an instrument that accurately 
measures the RNA concentration (ng/µL) contained in the eluate while using only 1.3 µL 
of material. In addition, the output of absorbance ratios 260/280 and 260/230, which refer 
to the presence of proteins and solvent residues, respectively, is used to assess RNA 
purity. The closer the absorbance ratios are to the value 2, the purer the RNA.  
The SuperScript IV Reverse Transcriptase cDNA Synthesis protocol (ThermoFisher 
Scientific) was used to conversing purified RNA into single-stranded cDNA by reverse 
transcription. 
3.4. Library preparation for 16S microbial communities  
For the construction of the libraries, a two-step PCR amplification are provided, 
each followed by an electrophoretic run in 1.5% agarose gel necessary to check the 
amplification and a purification propedeutic for the following step. An illustrative 
example of this method is shown in Figure 3.4. [33]  
 
Figure 3.4. Library preparation using a two-step PCR amplification protocol 
 




3.4.1. First PCR step 
The first PCR amplification involves the pair of tailed primers Pro341F/ Pro805R 
which contains a part of the sequence capable of specific binding for V3–V4 
hypervariable region of Prokaryote 16S rRNA gene, and a part that acts as an overhang 
adapter for the binding of primers that will be used in the second PCR step. Table 3.3 
shows the sequences of the primers were used. [97] The primers were selected to amplify 
simultaneously Bacteria and Archaea genomes, followed by sequencing on an Illumina 
MiSeq platform.   
Table 3.3. Primers used for the first PCR step 
16S_PCR_Forward 
(Pro341F)  
5′-TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA CAG 
CCT ACG GGN BGC ASC AG-3′ 
16S_PCR_Reverse  
(Pro805R) 
5′-GTC TCG TGG GCT CGG AGA TGT GTA TAA GAG ACA 
GGA CTA CNV GGG TAT CTA ATC C-3′ 
 
Table 3.4 below shows the quantity of the individual reagents used in the first PCR 
reaction mixture. Sample amplification occurred in triplicate to increase the likelihood that 
even less represented sequences will be amplified. On the other hand, to reduce errors 
associated with taking incorrect amounts of Taq polymerase, a single mix is prepared for 
all samples. 20 µL of cDNA templates were added to the mix, at the most suitable 
dilution. The cDNA templates were diluted with Rnase-free water to obtain a final 
concentration of 50 ng cDNA/µL.  
Table 3.4. Reaction mixture for the first PCR step 
Reagents Volume 1X (µL) 
HF Buffer 5X 12 
dNTPs 25 mM 0.6 
Primer 16S_PCR_Forward 10 µM  1.5 
Primer 16S_PCR_Reverse 10 µM 1.5 
Tag Phusion 1.5 
H20 BDH (Rnase-free water) 22.9 








Specifications of PCR thermocycler comprised an initial denaturation at 94°C for 3 
min, followed by 35 cycles of annealing at 94°C for 45 sec, 57°C for 60 sec, and 72°C for 
90 sec and a final extension at 72°C for 10 min.  
To verify the accurate amplification of the 16S rRNA, after PCR step, the triplicates 
were pooled in a single pool, from which a volume of 5 µL was taken for the 1.5 % 
agarose gel electrophoresis. The gel obtained with 150 ml of agarose solution 1.5% (2.25 
g) and 15μl of cyber safe to verify the amplification. The 100 bp marker has been loaded 
in 1.3 μl. Samples were loaded using 5 μl of amplicon DNA (18-01-2020) and 5 μl of 
Loading dye 2X. The run was performed at 120V for 32 min. In our study, we wanted to 
find a band that was somewhat smaller than 500 bp, therefore the 100 bp molecular 
weight marker was chosen.  
Once the presence of the bands and the correct size have been verified, it is 
necessary to proceed with the purification step to select the amplicons of about 500 bp and 
to eliminate excess dNTPs, primer dimers, and the Taq polymerase. Purification was 
performed with the SPRIselect reagent Kit (Beckman Coulter Genomics), which is 
magnetic beads-based purification. The protocol provides for the withdrawal of all the 
amplified available, and therefore in our case of 55 µL, to which the magnetic beads at a 
concentration of 0.8X are added. Using the pipette to mix up and down in order to 
facilitate the binding of the amplicons with the beads and, to further increase the binding 
efficiency, then vortexing and incubating the suspension for 3 minutes at room 
temperature. The mixture was then placed on a magnetic station, at which the magnet will 
attract and settle to the SPRI beads. The amplicons were linked to the beads, while the 
transparent supernatant containing dNTP's, primer dimers and Taq polymerase was 
subsequently taken and eliminated. The beads were then washed with 180 µL of 85% 
ethanol at room temperature for 30 seconds. The elution of the amplicon from the beads 
occurs with 52.5 µL of BDH water, which has a greater affinity with DNA than the beads. 
After placing the water in the well, it is necessary to mix well, holding the plate out of the 
magnet, and making sure that the suspension is well resuspended; at this point the plate 
can be transferred again into the magnet which will attract the beads allowing us to 









3.4.2. Second PCR step  
In the second PCR step, two pairs of primers were used, one of which is 
characterized by seven nucleotides that differ for each sample and is called the Barcoding 
primer (Primer BC). Thanks to the different sequence, the BC primer allows us to 
uniquely identify the sample even after running the Pool, or having gathered libraries of 
multiple samples in a single tube. The two primer pairs shown in table 3.5 are bound to 
the amplicon obtained from the first amplification step.  
Table 3.5. Primers used for the second PCR step 
2bRAD_am
pl_F  
5′-AAT GAT ACG GCG ACC ACC GA-3′ 
2bRAD_am
pl_R 
5′-CAA GCA GAA GAC GGC ATA CGA-3′ 
2bRAD_BC  CAAGCAGAAGACGGCATACGAGATcatctttGTGACTGGAGTTCAGAC
GTGTGCTCTTCCGATC 
2bRAD_for  AAT GAT ACG GCG ACC ACC GAG ATC TAC ACT CTT TCC CTA 
CAC GAC GCT CTT CCG ATC T 
Table 3.6 below shows the reaction mix for the second PCR step. The 50 µL 
obtained from the mix were separated into three different wells and placed in the thermal 
cycler where the amplification took place following the thermal protocol comprised an 
initial denaturation at 98°C for 3 min, followed by 10 cycles of annealing at 98°C for 30 
sec, 60°C for 30 sec, and 72°C for 45 sec and a final extension at 72°C for 7 min.  
Table 3.6. Reaction mixture for the second PCR step 
Reagents Volume 1X (µL) 
HF Buffer 5X 10 
dNTPs 25 mM 0.625 
Primer 2bRAD_ampl_F 10 µM  1 
Primer 2bRAD_ampl_R 10 µM 1 
Primer 2bRAD_BC 10 µM 2.5 
Primer 2bRAD_for 10 µM 2.5 
Tag Phusion 1 
H20 BDH (Rnase-free water) 26.375 
cDNA template 5 
Total 50 
 




After amplification, the triplicates of each sample were combined in a single pool 
from which 5 µL were taken to perform the amplification control in 1.5% agarose gel 
electrophoresis. With the second amplification the expected size of the amplicons 
increased to approximately 620 bp as the added primers have a very long sequence.  
After verifying the presence of a single band at the correct height, we proceeded 
with the second purification with the SPRIselect beads method. The protocol is similar to 
that described for the first purification but in this case the volume of BDH water with 
which eluting the DNA from the beads is reduced to 27.5 µL and a volume of 25 µL is 
taken from the well of the plate to transfer it to a new one.  
After purification, an electrophoretic run is performed in 1.5% agarose gel to verify 
the successful elimination of the primer dimers and reagents necessary for the execution 
of the PCR reaction, and to verify the presence of the band at the expected size. 
3.4.3. Library quantification by fluorimetric method and obtaining the pool 
We used the Qubit fluorometer (Invitrogen, Life technologies) to quantify the 
nucleic acids and proteins contained in a sample by exploiting the use of probes capable of 
binding specific target molecules. When the probes are linked to their respective 
molecules, they emit fluorescence with an intensity that is a few orders of magnitude 
higher than the intensity they emit when the bond does not occur. Unlike the Nanodrop, 
using this method it is possible to quantify only the molecule of our interest, DNA in this 
case, and not all those molecules capable of absorbing at 260 nm. Another advantage 
deriving from the use of Qubit is that of being able to quantify only intact DNA and not 
degraded DNA or single dNTP's since the fluorophore intercalates only at the double 
helix. It is therefore deduced that the quantitation of Qubit is much more sensitive and 
specific even at low concentrations of DNA. The reagents used for carrying out the assay 
are contained in the Qubit Assay Kit BR (Invitrogen, Life technologies) but, having a 
large number of samples to be analyzed the fluorescence measurement was carried out in 
the plate using the instrument for real time (Stratagene). Performing the plate 
measurement using the tool for real time allows us to use a lower sample volume than 
what would be needed if the measurement were to take place with the Qubit fluorometer. 
The kit contains the fluorescent dyes fluorophore, with which to quantify the DNA 
by measuring the fluorescence, and two standards (STD 100 ng/µL - STD 0 ng/µL) with 
 




which to build the calibration line to obtain the equation, necessary in order to calculate 
the concentration of the samples starting from the detected fluorescence data. 
The quantification mix contained the fluorophore and the buffer in the ratio 1: 200. 
In the special real-time plate, 19 µL of mix and 1 µL of sample were placed in each well, 
shaken by vortexing for two minutes and then centrifuged at 3,000 rpm for two minutes, 
and care must be taken not to expose the fluorophore to light as it is very sensitive to 
degradation. 
The quantification of the DNA contained in each sample is essential for obtaining an 
equimolar pool, or a pool in which each sample is equally represented. Equimolarity is 
fundamental in the sequencing phase as it prevents a sample present in greater quantities 
and therefore more likely to be sequenced than others. Therefore, by quantifying each 
sample we are able to calculate the volume to be taken from the well necessary to have an 
equal concentration among all the samples. 
3.4.4. Qualitative and quantitative assessment of the Pool 
For the qualitative evaluation of the pool, we used Agilent 2100 Bioanalyzer 
instrument which involves running the samples in a miniaturized Chip45 containing the 
gel. This method is particularly advantageous since it is quite sensitive and it requires a 
volume of only 1 µL of DNA. The chip (DNA 1000) has 16 wells, 12 of which are 
intended for the samples, connected together by glass microchannels containing the Gel-
Dye which allows the separation of the sample on the basis of the molecular weight. The 
principle is similar to that of a classical electrophoretic run but the times of separation are 
significantly reduced, the sensitivity is much higher and the detection of the DNA 
fragments takes place through a laser-induced fluorescence that uses a fluorescent dye 
intercalating the DNA molecule. Figure 3.5 shows the DNA analysis Bioanalyzer chip. 
 
Figure 3.5. DNA analysis Bioanalyzer chip 
 




An amount of 9 µL of Gel-Dye Mix were placed in the well indicated with the letter 
G circled in black and, by means of the pressure generated by a syringe, pushed for 1 
minute, the gel was distributed evenly within the microchannels. Subsequently, another 9 
µL of Gel-Dye Mix were placed in the two wells where the letter G is indicated, in the 
well with the scale symbol, 1 µL of Ladder has also been added. The marker is an internal 
control that serves to delimit the run while the Ladder is the molecular weight marker that 
allows identifying the length of the fragments contained in the pool. In each of the 12 
wells intended for samples was placed 1 µL of DNA. The Chip was first shaken by 
vortexing for 1 minute and then inserted into the Bioanalyzer instrument for the run and 
the relative identification of the fragments present in the sample. 
Although the Bioanalyzer also possible to perform a quantification of the sample, by 
calculating the area under the peak corresponding to the intensity of fluorescence detected 
at the passage of the amplicon, it was decided to use the Bioanalyzer only to evaluate the 
quality, and to use the Qubit for quantification. The quantification of the pool is carried 
out in a single tube using the Qubit Assay Kit BR and not in a 96 plate, using the 
instrument for real-time, as in the case of the quantification of libraries. The mix consists 
of 199 µL of buffer and 1 µL of fluorophore, both provided by the Kit. Before 
quantification, the instrument must be calibrated by inserting standard 1, corresponding to 
0 ng/µL, and then standard 2, corresponding to 100 ng/µL, in the appropriate space. After 
calibration, the pool can therefore be quantified using a solution containing 198 µL of the 
previously prepared mix and 2 µL of sample. 
3.5. Sequencing and Bioinformatics Analysis 
3.5.1. Sequencing 
The library pool in equimolar ratios (also called balancing) was then shipped to UC 
Davis Genome Center (California) for sequencing and demultiplexing. The center itself 
performed the sequencing using the Illumina MiSeq platform with a paired-end 300-cycle 
run, producing forward and reverse reads of length equal to 300 bp and partly 
overlapping. To demultiplex sequences we need to know which barcode sequence 
corresponds to each sample. Using the CASAVA v1.8 (Illumina) instrument, the Illumina 
MiSeq sequences (2 × 300 bp) were demultiplexed, which means that the reads were 
separated based on the assigned barcode in order to distinguish the different samples. 
After demultiplexing, you can figure out how many sequences were obtained per sample 
and get a summary of the sequence quality distribution at each point in the sequence data. 
 





Output provided by the sequencing center is in FASTQ format, a text format where 
each nucleotide of the sequence is associated with the quality parameter (Phred Quality 
Score). The quality parameter expresses, through a numerical value, the accuracy of 
attribution of each nucleotide, the higher the associated value, the more accuracy (see 
table 3.7).  
Table 3.7. Phred Quality Score 
Phred Quality Score Error Accuracy (1 - Error) 
10 1 in 10 = 10% 90% 
20 1 in 100 = 1% 99% 
30 1 in 1000 = 0.1% 99.9% 
40 1 in 10000 = 0.01% 99.99% 
50 1 in 100000 = 0.001% 99.999% 
60 1 in 1000000 = 0.0001% 99.9999% 
The quality of the raw sequence data received from the UC Davis center was 
subsequently evaluated using the FastQC (Babraham Bioinformatics) software (version 
0.11.7; available at: https://www.bioinformatics.babraham.ac.uk/projects/fastqc/), which 
provides the Phred Quality Scores Chart for each nucleotide of the reads using a graphic 
output that divides the plot into three color areas different according to the quality scores.  
The processing of the sequences was performed using multiple computer software 
and the various steps are outlined in Figure 3.6.   
 





Figure 3.6. Workflow of the bioinformatics analysis performed 
3.5.3. QIIME2 
The bioinformatic analysis was carried out using Quantitative Insights Into 
Microbial Ecology version 2 (QIIME2 2021.2) software. This is a bioinformatics pipeline 
that starts with raw DNA sequences obtained by Illumina or other platforms and works its 
way to microbiome analysis. [14] A GitHub repository can be found at: 
https://github.com/beiko-lab/mimb_16S which provides us the scripts for downloading a 
sample dataset. The software asks for sequence data in FASTQ format that has been 
named using the Illumina naming convention. [44] 
Input/output files in QIIME2 are divided into two categories: QIIME artifacts (.qza) 
and QIIME visualizations (.qzv). Using the “SampleData 
[PairedEndSequencesWithQuality]” semantic type, we can import the demultiplexed raw 
sequence data into the QIIME2 artifact. The residual artificial sequences (barcodes, 
primers) were then removed from the sequencing data by implementing cutadapt 2021.2.0 
in QIIME2 artifact with using q2-cutadapt plugin and trim-paired command with the 
primer of the first step PCR (forward (17 bp and reverse (21 bp) primes). [70] The 
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trimmed sequence data files were quality filtered by cutting bases with an average quality 
score below 20.  
Following, denoised paired-end sequences (F280 and R220) were merged by 
DADA2 pipeline. Non-overlapping regions, chimeric sequences, and singletons were 
discarded, and FeatureTable[Frequency] and FeatureData[Sequence] QIIME2 artifacts 
were generated using q2-dada2 plugin which implements DADA2 pipeline in QIIME2 
[17].    
For taxonomic classification, first, we downloaded the Naive Bayes classifier 
artifact that was trained on SILVA 16S rRNA reference database (silva_132_99) 
(available at: https://www.arb-silva.de/) and clustered at 99% sequence similarity. [13] 
This progress was carried out by using q2-feature-classifier plugin in QIIME2 and the 
Naive Bayes sklearn-based taxonomy classifier with a default confidence of 0.7.  
For more detail, you can see table 3.8 below, which illustrates some useful 
commands that were used in bioinformatic analysis with QIIME2. 
  
 




Table 3.8. QIIME2 commands 
The commands were used Functionality 
qiime tools import  
--type ’SampleData[PairedEndSequencesWithQuality]’  




















qiime dada2 denoise-paired 
--i-demultiplexed-seqs trimmed-seq.qza 











qiime feature-classifier classify-sklearn  
--i-classifier silva-132-99-nb-classifier.qza  










3.6. Statistical Analysis with Calypso software 
Two QIIME 2 output files were exported, namely FeatureTable[Frequency] as 
feature-table.biom and FeatureData[Taxonomy] were imported to Calypso version 8.84 
software for statistical analyses purpose. The Calypso software is online, easy for non-
expert users to mine, interpret, and compare the taxonomic classification of 16S rRNA 
genes in metagenomic datasets. [116]  
For the 16S rRNA amplicon sequencing dataset, Chloroplast and/or Cyanobacteria 
were eliminated by using data filtering in Calypso. The OTU abundance data were 
normalized via the total sum normalization (TSS) method combined with square root data 
transformation (Hellinger transformation) before doing the calculation of Bray-Curtis 
dissimilarity.  
Adonis is a multivariate method designed to achieve the same goals as multivariate 
analysis of variance (MANOVA) and based on distance matrices permutations. Adonis 
can assist us figure out if differences in community composition are due to experimental 
treatments or control variables. Adonis+ determines if the different explanatory variables 
can explain the variation in community composition. We determined the p-value using the 
Adonis+ Multivariate Analysis, which calculates the likelihood of detecting a difference 
between groups, and the p-value is supposed to imply statistical significance if it less than 
0.05. [96] 
Rarefaction analysis can be used to determine how well metagenomic sequence 
reads cover the microbial communities. Microbial sequences are picked at random from 
each sample in a rarefaction analysis. The number of observed species is enumerated and 
shown as a function of the number of sampled sequences for each subsample. If the 
underlying microbial community is well represented by the sequencing data, the slope of 
the rarefaction curve reflects that. According to rarefaction curve, the richness was 
visualized and can expressed the alpha-diversity, which is the index that explains the 
variability of the microorganisms within the individual samples grouped according to 
precise categorical variables. [96] A steep slope suggests that a significant portion of the 
species diversity is still unknown. If the curve flattens out to the right, a sufficient number 
of sequence reads has been gathered, and additional sampling will likely reveal only a few 
additional species. 
 




In Calypso software, we can also evaluate alpha-diversity among amplicon sequence 
datasets based on the construction of HeatMap. The HeatMap allow us to identify the 
most represented taxa within the dataset and output a graphic representation that uses a 
color scale to indicate the abundance of individual taxa within the samples. [96] 
To evaluate the microbial diversity between the samples, beta-diversity is calculated 
by producing the 2D PCoA Plot (Principal Coordinates Analysis) which uses orthogonal 
axes to map the samples; the first axis represents the greatest amount of variability, the 
second contains most of the remaining variability and so on depending on the number of 
axes that you want to use. The metric used to obtain the PCoA Plot is the Bray-Curtis 
which performs a qualitative analysis, considering the phylogenetic information, 












4. RESULTS AND DISCUSSION 
4.1. Results 
4.1.1. Milk sampling and cheese-making 
An aliquot of 50 ml of healthy cow milk was obtained on d 17 in the morning 
between 6:00 and 7:00 under sterile conditions to make sure that the milk samples had a 
good quality, limited as much as possible the contamination of exogenous bacteria. The 
cheese-making was using the raw cow’s milk collected from the milking of the evening d 
16 and the morning d 17, and then made the cheese on the d 17, with the added starter 
culture contains strains of streptococci and thermophilic lactobacilli. In general, the 
quality of the cheese samples was good. The milk and cheese samples were pre-treated as 
mentioned in section 3.2 of the materials and method chapter, and were stored at -80 °C to 
be used in further RNA extraction.  
4.1.2. RNA extraction and cDNA synthesis 
The RNA was extracted from two different matrices, milk and cheese; however, 
having a fairly similar extraction protocol. Except for the homogenization with Zirconia 
Silica beads steps prior to RNA extraction, is only required for cheeses. In total, 54 
samples were extracted: 36 extracted RNA relating to the testingof active milk microbiota 
and 18 extracted RNA relating to the testing of active cheese microbiota, of which 
libraries were built for a single sequencing run within the Miseq Illumina® 2x300 
platform. At the end of each RNA extraction session, the quality and quantity of the 
extracted RNA was evaluated with the Nanodrop ND-1000 according to the protocol was 
described in the section 3.3 of materials and method chapter.  
The two different matrices used do not showed significantly different in term of 
extraction efficiencies. For the RNA extraction qualitative, both nanodrop output of milk 
and cheese matrices reports the absorbance ratios 260/280 are quite close to the optimal 
value 2, while the 260/230 ratios are lower. The absorbance ratios 260/280 and 260/230 
are very variable among different samples. It is a normal condition when you extract DNA 
or RNA from complex matrices. Concerning the quantification of the extracted RNA you 
usually do not infer from biological explanatory variables. This means that you aspect a 
range of concentration.  
 
 




You consider that for the following amplifications performing different tests to 
understand what dilution of DNA gives you the more suitable outcome. The quality of the 
extracted RNA and obtained DNA was tested on PCR real-time, using one specific primer 
for bacteria (Nadkarni) and one specific primer for bovine DNA. The results highlighted a 
good amplification of the bacterial DNA. Moreover, comparing the output of the primer 
for bovine DNA and bacteria DNA it was possible to understand that bacterial DNA was 
advantaged in amplification when the dilution increased. 
After reversed-transcription, the cDNA templates were diluted with RNase-free 
water to obtain a final concentration of 50 ng cDNA/µL.  
4.1.3. Library preparation for 16S microbial communities 
Despite the low efficiency of RNA extraction from milk and cheese matrices, 
following the first PCR amplification required for the construction of the sequencing 
library, all samples show the band at the expected height in 1.5% agarose gel. The bands 
in milk samples are not clearly visible, while all cheese samples show the clearer bands. 
 Figure 4.1 shows the photo of a gel obtained following the first amplification step, 
and it is noted that despite the variability of the intensity of the band, it is present in all the 
samples and absent in the three sterility controls. 
 
Figure 4.1. First PCR step quality was checked by 1.5 % agarose gel electrophoresis 
 




Continuing with the purification steps and with the second PCR amplification in no 
case is the presence of nonspecifics observed in the gel, and by comparison with the 
molecular weight marker, it was possible to check that the fragment increased in size 
thanks to the bond with the long primers used in the library building process. (Firgure 4.2) 
 
Figure 4.2. Second PCR step quality was checked by 1.5 % agarose gel electrophoresis 
After the construction of the libraries, each of them was quantified with a 
fluorimetric method to obtain an equimolar pool that could be transformed to the 
sequencing center. 
After obtaining the library pool for sequencing, an internal quality control was 
performed using Bioanalyzer, in order to identify the presence of any non-specific primer 
dimers and verifying that the fragments present inside were of the expected size.  
The output obtained from the Bioanalyzer is shown in Figure 4.3. It identifies the 
first and last peaks corresponding to the marker, loaded in each well, while the central 
peak corresponding to the fragments of the libraries contained in the pool. The peaks of 
the marker represent internal control, which is necessary for the operator to verify that the 








The peak corresponding to 596 bp represents the fragments of the amplified V3 and 
V4 regions of the 16S gene after the two-step PCR amplification. In the Figure 4.3 there is 
no further peaks are observed that means there is no non-specific DNA molecules, so we 
can confirm that the primers are highly specific and the purification steps have occurred 
correctly by selecting only the fragments of interest. 
Another characteristic can demonstrate the good quality of the pool is the narrow 
shape of the peak, which denotes that the fragments present have a very similar length to 
each other, although not the same since each bacterial species will have a different number 
of nucleotides. 
 
Figure 4.3. Bionalyzer of pool 
4.1.4. Sequencing Quality Assessment 
The quality of the raw sequences obtained from the sequencing center (sequencing 
with the Illumina MiSeq 2x300 platform) was evaluated with the FASTQC software 
which returned the graphic output shown in Figure 4.4. The nucleotide positions of the 
generated reads are indicated in the horizontal axis; the Phred quality score is shown by 
the vertical axis. By using this graphic representation, it is possible to define the quality of 
the sequences for each nucleotide position. 
As we can see from Figure 4.4, the terminal nucleotides always have a lower quality 
than the other positions and the quality of the Reverse sequence (Figure 4.4-B) always 
tends to decrease some positions earlier than the Forward sequence (Figure 4.4-A). 
 
 






Figure 4.4. Graphical display with FastQC software of the quality of the raw sequences  
A: Forward, B: Reverse
Clearly, the quality of the raw sequences obtained is good since in almost all the 
nucleotide positions there was at least one sequence that presented a Phred quality score 
higher than Q20. The raw sequences were then trimmed and merged with QIIME2, and 
were normalized and filtered with Calyso.  
Sequencing of the 54 samples analyzed in the Illumina MiSeq 2x300 platform 
generated a total of 4,190,103 raw sequences; after filtering and normalization with 










4.1.5. Evaluation of the effect of Bentonites additives on bacterial community of 
milk and cheese 
The addition of Bentonites mycotoxin binders into feeds of Italian Friesian cows 
was found to have no effect on the diversity of active milk and cheese bacterial 
communities. The p-value of 2.97e-1 was obtained by doing Adonis+ Multivariate 
Analysis, showing non-significant (p > 0.05) and hence suggesting that the diversity of 
active microbiota in milk and cheese was unaffected by different amounts of Bentonites 
feed additives. 
On the other hand, the variance in microbial composition could be explained by the 
matrix-based explanatory variables (i.e. milk and cheese) since the p-value of 3.3e-05 
shows a statistically significant (p < 0.05); thus, the diversity of active microbiota in milk 
and cheese of cows fed with Bentonites additives was still clear and unaffected. In 
addition, within three treatment periods, the diversity of active microbiota also indicates 
significance (p < 0.05), indicating that the dose and the time of use of Bentonites did not 
affect the microbial community. 
Table 4.1. p-value obtained by a means of Adonis+ Multivariate Analysis 
Explanatory variables p-value 
Bentonites (B0, B50, B100) 0.297 
Matrix (milk,cheese) 0.000333 
Period (T1, T2, T3) 0.00367 
Figure 4.5 shows the rarefaction curve that describes the alpha-diversity index 
(richness), which is explains the variability of the microorganisms within the individual 
samples grouped according to categorical variables. The index was calculated according to 
the matrix-based categorical variables (4.5-A) and the treatment-based categorical 
variables (4.5-B).  
In both cases, the slope of the rarefaction curve obtained tends to flattered to the 
right, which indicates that a reasonable number of sequence reads has been obtained and 
more intensive sampling is likely to yield only a few additional species. Therefore, the 
information contained in the dataset is sufficient to describe the microbial diversity.  
Clearly, the bacterial species richness associated with the milk groups is much 
higher than that of the cheese groups. 
 






Figure 4.5. Rarefaction curves of alpha diversity index (richness); 
 A: variable matrices, B: variable Bentonite treatments 
The groups of samples relating to the two different types of matrices are 
significantly spaced out (Figure 4.5-A), indicating significant separated clusters between 
active milk microbiota and active cheese microbiota. From figure 4.5-B it can be seen that 
the groups relating to Bentonite treated and un-treated do not distance themselves but are 
superimposed on each other. And so this confirms that the Bentonite feed additives do not 











By the means of 2D principal coordinate analysis (PCoA) plots, beta-diversity can 
be assessed to establish how microbial diversity varies between samples. Figure 4.6 
represents the PCoA carried out with the Bray-Curtis dissimilarity which takes into 
account the phylogenetic distance between the OTUs present in the samples but not their 
abundance. From figure 4.6 it can be seen that the groups relating to the three different 
Bentonite treatments (B0, B50, and B100) do not distance themselves but are 
superimposed on each other. On the other hand, the groups of samples relating to the two 
matrices (Milk and cheese) are clearly spaced out.  
 
   
Figure 4.6. Principal coordinate analysis (PCoA) based on Bray-Curtis dissimilarity  











Figures 4.7 show the heatmap obtained with the dataset of the experimentation; the 
20 most represented bacterial phyla and families are reported by means of graphic output. 
The heatmap uses a color scale to identify the abundance of each taxa within each sample, 
thus summarizing in an image the partial microbial diversity within the sample itself, and 
between the samples. Positioned on the horizontal (x) axis, the grouping is shown based 
on the compositional similarity between the samples; the grouping carried out according 
to the similarity of abundance between the taxa is shown on the vertical (y) axis.  
At the phylum level, there is no separation shown in the heatmap between milk and 
cheese matrix; whereas at the family level, there is a transparent distinction between the 
heatmap of milk and cheese matrix. The bacterial families shown all samples belong 
mainly to the Firmicutes, Poteobacteria, Bacteroidetes and Actinobacteria phylum, 
confirming what is reported in the literature. [71][117]. There is a higher amount of taxa 
in milk samples in compare to cheese. In cheese, we obtained the Steptococcus that was 
introduced from the starter culture. Moreover, within each taxa, we can see both un-
treated (B0) and treated (B50, B100) Bentonites groups includes; thus, it can confirm that 
Bentonites usage doses did not have an effect in active microbial community. 
It can be clearly seen that the active microbiota in milk and cheese after cows were 
fed a feed supplemented with Bentonites did not change in terms of diversity and gave 











Figure 4.7. Heatmap of active milk and cheese bacterial communities  










Milk and cheese are nutritious foods that have positive effects on human health, 
such as preventing cardiovascular disease, maintaining weight; thus, they are widely 
consumed worldwide. [118] Microbial community in milk is believed to contribute 
significantly to the establishment of gut microbiota, thereby conferring beneficial effects 
on consumer health. At the same time, microorganisms also play an important role in the 
composition and flavor of dairy products, which will determine the choice of consumers. 
Indeed, effective quality management of dairy products requires knowledge of altered 
microbiota activity in response to external influences, such as changes in the cow's diet or 
added food additives. [89][100] 
In addition, there is increasing concern about the harmful effects of mycotoxins on 
consumer health when mycotoxins are contaminated with the milk of cows fed toxin-
contaminated feedstuff. In fact, dairy cows are often fed a compound cattle feed that is 
blended from various raw materials and additives, including grains, forage, silage, agro-
industrial by-products, minerals, and vitamins. Each ingredient can be unintentionally 
contaminated with one or some kinds of mycotoxins. It is an important reason to 
increasing the risk of mycotoxicoses in cows. [40] Mycotoxins can affect directly to the 
health and performance of animals, which in turn leads to effects on economic growth and 
international commerce. Moreover, some mycotoxins can pass into the milk, such as 
aflatoxin M1 (AFM1); thus, it poses a major public health risk. Dairy products are an 
integral part of the diets of young children and the elderly, who are less resistant to this 
toxin, and hence they can be more susceptible to infections.  
Since 2009, the European Commission has officially authorized the use of 
mycotoxin binders in animal feed, as a common and simple method for farmers and 
fodder manufacturers. [27] Mycotoxin binders are added to the cattle feed to prevent 
mycotoxins from being absorbed in the GI tract, as well as their move to the blood 
circulation and target organs, decreasing their bioavailability after ingestion, and thereby 
diminishing harmful effects of them in individuals. [61] The mechanism of the binders is 
forming mycotoxin-adsorbent complexes that are able to pass through the animal and is 
then excreted via the faeces. [107] However, there is a scarcity of research data regarding 
the impact of mycotoxin binders on animal products, such as cow milk. As a result, 
farmers and the feed industry must be cautious when supplementing these anti-mycotoxin 
mineral adsorbents, and further studies are needed in this area. [27] Our research generally 
 




focuses on Bentonite that is a commonly used toxic binder today. Therefore, the obtained 
results will be a premise for studies on other types of anti-mycotoxin agents. 
The introduction of independent culture methods, and in particular of NGS, has 
made it possible to significantly increase the ability to study complex microbial 
community. The methods commonly used in the past were not able to make a reliable 
evaluation of the active bacterial communities because: a culture-dependent approach is 
not able to identify the bacteria considered non-cultivable and the independent culture 
methods prior to NGS such as DGGE, T-RFLP, and Sequencing Sanger have low 
taxonomic resolution and inadequate sampling depth. The use of NGS techniques 
introduces a lower number of errors than cultivation techniques, thus allowing the 
definition of the relationships between the sample and environmental factors and a better 
description of the actual microbial diversity contained [62][80][89] Although NGS 
techniques are widely used, there are still some aspects that need improvement and fine-
tuning.  
The majority of published milk and cheese microbiome data commonly based on 
DNA-based methods with amplification and sequencing of 16S rRNA genes. 
[71][89][100][117]. However, considering that DNA-based analysis cannot discriminate 
between active and inactive species, RNA-based amplicon sequencing has become 
popular in microbial ecology investigations as an alternative method to generate 
information of active members in the communities of different environments. [93] The 
RNA-based approach offer more promise thanks to the existence of a positive association 
between the content of ribosomal RNA (rRNA) and the metabolic activity of 
microorganisms, allowing the prediction of metabolically active microbial community 
structures. [1][4] Following extraction, total RNA is reverse-transcribed to cDNA, and 
cDNAs are analyzed using high-throughput sequencing technologies (RNA-seq). The 
Illumina Miseq platform was used in this experiment as it is a powerful and rapid 
sequencing platform for characterizing the microbial composition by sequencing the 16S 
rRNA gene. [49] The use of an RNA template in a 16S metabarcoding (targeting cDNA 
obtained through reverse-transcription PCR) analysis provides the relative amounts of the 








Although 16S rRNA-based metabarcoding shows great potential in microbial 
taxonomy, there are still many challenges that remain in the research using this method, 
particularly the difficulty in extracting RNA of good quality, sample preparation and 
handling caution due to RNA’s low stability, and the ubiquitous presence of RNases, as 
well as bioinformatics issues relating to sequence reconstruction, annotation, and 
statistical analysis. [60]  
For the phylogenetic investigation, the complete gene is not amplified and 
sequenced but only an amplicon of about 470 bp including the hypervariable regions V3 
and V4. In order for samples to be sequenced, it is necessary to build libraries consisting 
of a set of fragments of nucleic acids representative of the sample itself. The library for 
the phylogenetic analysis of microbial communities was obtained by means of the 
convenient two-step PCR amplification reactions that firstly used a pair of 16S universal 
primers and then secondly used pair of primers capable of being recognized by the 
Illumina platform and one of the latter contains its own internal a barcode sequence 
necessary to distinguish the individual samples within the pool. [49][97]  
In our current study, at the family level, there is a transparent distinction between 
the heatmap of milk and cheese matrix. In milk samples of our study, the overall 
dominance of the phyla: Firmicutes, Poteobacteria, Bacteroidetes and Actinobacteria are 
in agreement with the results of previous DNA-based studies. [117] In cheese samples of 
our study, the overall dominance of the phyla: Firmicutes, Actinobacteria, and 
Proteobacteria are in agreement with the results of other DNA-based studies. [71] There 
is a higher amount of taxa in milk samples in compare to cheese. In cheese, we obtained 
the Steptococcus that was introduced from the starter culture. Moreover, within each taxa, 
we can see both un-treated (B0) and treated (B50, B100) Bentonites groups includes; thus, 
it can confirm that Bentonites usage doses did not have an effect in active microbial 
community. 
In our study, the diversity and composition of the active microbiota in milk and 
cheese after cows were fed a feed supplemented with Bentonites was virtually unchanged, 
demonstrating a neutral effect of this toxin binder. This is also partly supported by the 
EFSA's previous scientific advice that mycotoxin binder is not absorbed once the animal 
ingests it; therefore it do not toxic to animals.  
 
 




The significance of this study suggests that it is possible to safely use mycotoxin 
binder Bentonites in the feed of dairy cows, as it helps to prevent the risks posed by 
mycotoxins on cow health and performance, but at the same time, does not reduce the 
diversity of active microbiota and does not affect the quality of animal products, here in 
particular, milk and cheese. Based on current result, we can improve our knowledge and 
confidence in the use of bentonites toxin binders in animal feed. Moreover, it will be the 
basis for similar studies on other toxic binders, or studies on other livestock such as 
chickens, pigs or horses. 
 
 





The RNA-based amplicon sequencing method enables for precise prediction of 
metabolically active bacteria and communities in milk and cheese. The capacity to 
distinguish between active and inactive, lysed or dead microorganisms is very important 
when studying the influence of various stimuli on active dairy microbial communities. 
The findings of this investigation revealed that Bentonites feed additives have no effect on 
diversity and composition of bacterial community.  
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